Drug Discovery Services Market Overview, Size, Share and Forecast 2031
The Drug Discovery Services Market in 2023 is US$ 19.7 billion, and is expected to reach US$ 59.02 billion by 2031 at a CAGR of 14.7%.
FutureWise Research published a report that analyzes Drug Discovery Services Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Drug Discovery Services research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Drug Discovery Services Market Sample
Drug Discovery Services Market Segmentation:
By Process
- Target Selection
- Target Validation
- Hit-to-Lead Identification
- Lead Optimization
- Candidate Validation
By Type
- Medicinal Chemistry
- Biology Services
- Drug Metabolism and Pharmacokinetics
By Drug Type
- Small Molecules
- Biologics
By Therapeutic Area
- Oncology
- Neurology
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Other Therapeutics Areas
By Company Type
- Tier 1 Pharmaceutical Companies
- Tier 2 Pharmaceutical Companies
- Tier 3 Pharmaceutical Companies
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Key Market Players:
- Thermo Fisher Scientific
- Merck
- GE Healthcare
- Albany Molecular Research, Inc (AMRI)
- Charles River Laboratories International
- Evotec
- Pharmaceutical Product Development, LLC. (Ppd)
- Jubilant Biosys
- Covance
- Genscript Biotech Corporation
- Aurigene Discovery Technologies
- Wuxi Apptec
- Syngene
- Eurofins Scientific
- GVK Biosciences Private Limited
- Laboratory Corporation of America Holdings
- Lonza Group AG
- Piramal Enterprises Ltd
- Viva Biotech
- Dalton Pharma Services
- Domainex
- Selvita S.A.
- SRI International
- BioDuro
Please visit full report of the Drug Discovery Services market @ Visit Drug Discovery Services Market
Competitive Landscape:
· Tier one players - market players with a significant share of the market
· Tier two players
· Players with rapid growth
· New Entries
FutureWise Key Takeaways:
- Prospects for growth
- Analysis of SWOT
- Key trends
- Key Data-points affecting market growth
Objectives of the Study:
- To provide report with an in-depth analysis of the Drug Discovery Services Market By Process, By Type, By Drug Type, By Therapeutic Area, By Company Type and By Region
- To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
- Analysis and forecasting of micro-markets, as well as the scope of the market.
- To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
- To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Flexible Delivery Model:
- With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
- Customization services are included with the purchase of any license type of report.
- Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com